Total Payments
$21,530
2024 Payments
$2,618
Companies
41
Transactions
849
Medicare Patients
1,228
Medicare Billing
$203,068
Payment Breakdown by Category
Food & Beverage$14,859 (69.0%)
Other$4,000 (18.6%)
Research$1,226 (5.7%)
Consulting$1,200 (5.6%)
Gifts$178.20 (0.8%)
Education$66.42 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,859 | 813 | 69.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,000 | 14 | 18.6% |
| Unspecified | $1,226 | 11 | 5.7% |
| Consulting Fee | $1,200 | 1 | 5.6% |
| Gift | $178.20 | 3 | 0.8% |
| Education | $66.42 | 7 | 0.3% |
Payments by Type
General
$20,303
838 transactions
Research
$1,226
11 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tandem Diabetes Care, Inc. | $4,000 | 14 | $0 (2020) |
| ABBVIE INC. | $2,386 | 104 | $0 (2024) |
| Lilly USA, LLC | $2,202 | 133 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,920 | 99 | $0 (2024) |
| Novo Nordisk Inc | $1,766 | 97 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,516 | 68 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $1,398 | 4 | $0 (2017) |
| Mannkind Corporation | $1,006 | 45 | $0 (2024) |
| Insulet Corporation | $685.53 | 32 | $0 (2024) |
| Corcept Therapeutics | $672.81 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,618 | 92 | ABBVIE INC. ($1,385) |
| 2023 | $1,950 | 92 | Lilly USA, LLC ($493.74) |
| 2022 | $2,354 | 126 | SANOFI-AVENTIS U.S. LLC ($389.43) |
| 2021 | $1,981 | 111 | Lilly USA, LLC ($419.79) |
| 2020 | $3,218 | 110 | Tandem Diabetes Care, Inc. ($1,100) |
| 2019 | $1,628 | 89 | Novo Nordisk Inc ($224.12) |
| 2018 | $4,420 | 114 | Tandem Diabetes Care, Inc. ($2,600) |
| 2017 | $3,360 | 115 | Valeant Pharmaceuticals North America LLC ($1,398) |
All Payment Transactions
849 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.63 | General |
| Category: Insulin Pump | ||||||
| 11/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: ANTI-DIABETIC | ||||||
| 11/19/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/05/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $27.07 | General |
| Category: Insulin Pump | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $11.08 | General |
| 10/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Endocrinology | ||||||
| 09/26/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Endocrinology | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism | ABBVIE INC. | $1,226 | 11 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 281 | 484 | $89,500 | $48,837 |
| 2022 | 2 | 291 | 548 | $101,375 | $54,452 |
| 2021 | 2 | 239 | 462 | $79,125 | $47,843 |
| 2020 | 6 | 417 | 629 | $105,019 | $51,936 |
Total Patients
1,228
Total Services
2,123
Medicare Billing
$203,068
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 420 | $73,500 | $40,790 | 55.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $16,000 | $8,047 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 476 | $83,375 | $46,046 | 55.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $18,000 | $8,406 | 46.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 196 | 419 | $68,425 | $41,819 | 61.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $10,700 | $6,025 | 56.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 207 | 416 | $61,140 | $33,176 | 54.3% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2020 | 62 | 63 | $16,135 | $6,740 | 41.8% |
| 95921 | Testing of autonomic (sympathetic) nervous system function | Office | 2020 | 63 | 64 | $12,369 | $4,568 | 36.9% |
| 93923 | Ultrasound study of arteries of both arms and legs | Office | 2020 | 34 | 34 | $8,526 | $3,747 | 44.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $5,800 | $3,420 | 59.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 22 | 23 | $1,050 | $283.82 | 27.0% |
About Dr. Vivian Rose, M.D
Dr. Vivian Rose, M.D is a Specialist healthcare provider based in Coral Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013020072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vivian Rose, M.D has received a total of $21,530 in payments from pharmaceutical and medical device companies, with $2,618 received in 2024. These payments were reported across 849 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($14,859).
As a Medicare-enrolled provider, Rose has provided services to 1,228 Medicare beneficiaries, totaling 2,123 services with total Medicare billing of $203,068. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Coral Springs, FL
- Active Since 08/16/2006
- Last Updated 05/20/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013020072
Products in Payments
- t-slim insulin pump (Device) $2,900
- CYCLOSET (Drug) $1,642
- FARXIGA (Drug) $1,478
- ARMOUR THYROID (Drug) $1,226
- t:slim X2 insulin pump (Device) $1,100
- SOLIQUA 100/33 (Biological) $1,032
- AFREZZA (Drug) $1,006
- Ozempic (Drug) $764.44
- SYNTHROID (Drug) $738.39
- JARDIANCE (Drug) $718.15
- Omnipod (Device) $685.53
- Korlym (Drug) $672.81
- TRULICITY (Drug) $536.51
- Rybelsus (Drug) $481.15
- JANUVIA (Drug) $474.60
- UNITHROID (Drug) $424.19
- TRADJENTA (Drug) $377.39
- INVOKANA (Drug) $367.82
- MOUNJARO (Drug) $361.05
- TOUJEO (Drug) $311.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Coral Springs
Dr. Neal Weinreb, M.d, M.D
Specialist — Payments: $335,680
Specialist $335,680
Jose Vindas Cordero, Md, MD
Specialist — Payments: $47,450
Specialist $47,450
Dr. Michael Zahalsky, M.d., P.a, M.D., P.A
Specialist — Payments: $21,285
Specialist $21,285
Dawn Scarzella, M.d, M.D
Specialist — Payments: $12,373
Specialist $12,373
Dr. Nesreen Kurtom, D.o, D.O
Specialist — Payments: $6,590
Specialist $6,590
Dr. Marsh Mceachrane, M.d, M.D
Specialist — Payments: $5,771
Specialist $5,771